Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
Pirelli Plans $1.2 Billion US Expansion as Italy Curbs Chinese Shareholder Influence
Pirelli announced a $1.0-1.2 billion multi-year plan to expand US manufacturing, including sensor-equipped 'Cyber Tyres.' The move comes as
Morgan Stanley Cuts Mosaic's 2027 Profit Forecast, Lowers Price Target to $26
Morgan Stanley trimmed its 2027 EBITDA forecast for Mosaic to $1.93 billion and lowered its price target to $26, warning that cash flow chal
Graham's Defense and Space Backlog Jumps 29% as Orders Outpace Deliveries
Graham's defense and space backlog surged 29% in fiscal 2026, with new orders still outpacing shipments. Oppenheimer sees $50 million in upg
Vedanta-Backed CopperTech Halts $423.5 Million NYSE IPO Amid Copper Stock Slump
CopperTech Metals has postponed its $423.5 million NYSE IPO due to recent volatility in copper stocks. The Global X Copper Miners ETF has fa
Nestlé Faces Long Road to Regain Trust After Baby Formula Recall Over Toxin Risk
Nestlé says some parents may not return after pulling baby formula over possible cereulide contamination. The food giant warns it could take
US Box Office Heads for Best Post-COVID Q2 as AMC Share Sale Dampens Mood
US movie theaters are set for their best post-COVID second quarter, with June ticket sales projected at $1.05 billion. However, AMC's latest
Sucro Shares Surge 13% on Strategic Review, Rules Out Full Sale
Sucro shares surged 13% after the company launched a strategic review to explore value-unlocking options like asset sales, joint ventures, a
Biodexa Prices Three-Part Fundraise, Stock Dips on Dilution Fears
Biodexa Pharmaceuticals has priced a three-part fundraise worth $3.5 million, combining a registered offering, private placement, and warran
Fox Factory Downgraded by BofA as Cost Cuts Fail to Offset Weak Demand
Bank of America Securities downgraded Fox Factory to underperform, arguing its cost-cut push may not be enough to lift 2026 earnings much. T
Pyxis Oncology Raises Up to $114M in Private Placement to Fund Micvo Studies
Pyxis Oncology is raising up to $114 million via a private placement, securing $50 million upfront to advance its drug candidate Micvo. The
Nestlé Sets 2026 Deadline to Remove Artificial Colors Globally, Testing Margins
Nestlé will remove artificial colors from all its products globally by 2026, after years of R&D. The shift responds to consumer demand for c
Cencora Chair Mark Durcan Buys $1M in Stock After Post-Earnings Dip
Cencora chair Mark Durcan bought 4,000 shares worth about $1 million after the stock fell following Q2 earnings. The purchase, flagged as un